Skip to content
Sunday, November 15, 2026
Dark BiotechnologyBIOTECH · GENETICS · DEVICES

Biotech News

Dated biotech reporting.

BiotechGeneticsDevicesResearchBiotech NewsTech News
A scientist adjusts a bioreactor control panel in a facility of glass and brushed steel, cool teal-white light, no logos or readouts.
Biotech News

Gilead and Lakefront Complete $1.675 Billion Ouro Medicines Acquisition

Gilead Sciences (Nasdaq: GILD) and Lakefront Biotherapeutics (Euronext and Nasdaq: LKFT) completed the acquisition of Ouro Medicines on June 4, 2026, with Gilead paying $1,675 million for all outstanding equity plus up to $500 million in contingent milestone payments, per the company's announcement.

A scientist in safety glasses adjusts a bioreactor control panel, gloved hand on steel, cool white-teal light across glass vessels, no logos.
Biotech News

Parabilis Medicines Raises Record $670 Million Biotech IPO

Parabilis Medicines, a startup developing peptide drugs for targets considered undruggable, raised $670 million in an initial public offering priced June 9, 2026, per BioPharma Dive's June 10 report — a record haul for a venture-backed biotech.

Two analysts comparing printed abstract pages against a journal proof under the cold white light of a glass-walled meeting room.
Biotech News

Why a Conference Abstract Is Not a Publication: Reading Meeting Data With Caution

A conference abstract is a preliminary disclosure, not a publication, and the evidence for treating it cautiously is quantitative: in a Journal of Clinical Oncology study of 74 phase III abstracts presented at the 2000 ASCO Annual Meeting, 74% had corresponding journal publications six years later, and the primary endpoint result differed by more than 5% between abstract and publication in 42% of comparisons.